Details
Stereochemistry | ACHIRAL |
Molecular Formula | C41H50N6O2 |
Molecular Weight | 658.8747 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(C)CC(C)(C)C1=CC(CC2=CC(=CC(N3N=C4C=CC=CC4=N3)=C2O)C(C)(C)CC(C)(C)C)=C(O)C(=C1)N5N=C6C=CC=CC6=N5
InChI
InChIKey=FQUNFJULCYSSOP-UHFFFAOYSA-N
InChI=1S/C41H50N6O2/c1-38(2,3)24-40(7,8)28-20-26(36(48)34(22-28)46-42-30-15-11-12-16-31(30)43-46)19-27-21-29(41(9,10)25-39(4,5)6)23-35(37(27)49)47-44-32-17-13-14-18-33(32)45-47/h11-18,20-23,48-49H,19,24-25H2,1-10H3
Bisoctrizole (Tinosorb M) is a hybrid type sun blocking agent acting as both chemical and physical sunscreen. Bisoctrizole is a hybrid UV absorber, the only organic UV filter produced and microfine organic particles (< 200 nm), like microfine zinc oxide and titanium dioxide. Where other organic UV absorbers need to be dissolved in either the oil or water phase, bisoctrizole dissolves poorly in both. It covers both UVA and UVB range. Furthermore, it does not degrade under sunlight and is not significantly absorbed into the skin. It appear highly compatible with many other common sun blocking agents. Overall, it appears to have a good safety profile, even though current safety data are insufficient and long-term human safety studies are lacking. Unlike some other organic sunscreen actives, it shows no estrogenic effects in vitro. Bisoctrizole is not approved by the U.S. Food and Drug Administration (FDA), but is approved in the EU and other parts of the world. Bisoctrizole is highly stable and also has a stabilizing effect on other UV absorbers, particularly the UVB blocker octyl methoxycinnamate (octinoxate). Bisoctrizole appears to be relatively non-toxic and rarely causes skin irritation. As with many synthetic chemicals, it is unclear whether bisoctrizole may produce low-level skin damage or systemic effects with long-term use. Considering that bisoctrizole is stable, poorly soluble and minimally absorbed by the skin, the risks appear to be low. Still, more research is on bisoctrizole safety is needed.
Originator
Approval Year
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C851
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
||
|
EU-Orphan Drug |
EU/3/05/262
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 234
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 532
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
||
|
Food Contact Sustance Notif, (FCN No.) |
FCN NO. 652
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
||
|
FDA ORPHAN DRUG |
199204
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
QQ-42
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
DTXSID2046703
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
3571576
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
759873
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
m2564
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | Merck Index | ||
|
8NT850T0YS
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
1075677
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
DB11262
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
1310510
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | RxNorm | ||
|
8586
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
103597-45-1
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
SUB87952
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
100000139401
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
C65266
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
3031
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
BISOCTRIZOLE
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
8NT850T0YS
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104957
Created by
admin on Fri Dec 15 15:48:21 GMT 2023 , Edited by admin on Fri Dec 15 15:48:21 GMT 2023
|
PRIMARY |
ACTIVE MOIETY